how to prescribe glp 1 GLP-1 prescriptions require a comprehensive approach GLP-1 Medications for Weight Loss:

Large and complex datasets are being generated using a combination of multiomics approaches, clinical assessments, and, increasingly, digital technologies

A randomized controlled trial of dapagliflozin plus once-weekly exenatide versus placebo in individuals with obesity and without diabetes: metabolic effects and markers associated with bodyweight loss

You may need to increase meal frequency from 2 meals per day (common on GLP-1 medications) to 3 meals plus snacks

The trial exhibited a favorable safety profile with mostly mild to moderate gastrointestinal adverse events, including diarrhea (38% versus 19% in placebo), constipation (27% versus none), and appetite loss (31% versus 8%)